Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.45 USD | -0.14% | +0.12% | +1.60% |
Chart calendar Taro Pharmaceutical Industries Ltd.
Upcoming events on Taro Pharmaceutical Industries Ltd.
Past events on Taro Pharmaceutical Industries Ltd.
2024-01-25 17:06 | Q3 2024 Earnings Release |
2023-12-28 04:00 | Annual General Meeting |
2023-10-26 17:00 | Q2 2024 Earnings Release |
2023-07-26 20:36 | Q1 2024 Earnings Release |
2023-05-23 19:00 | Q4 2023 Earnings Release |
2023-01-24 17:43 | Q3 2023 Earnings Release |
2022-10-27 18:39 | Interim 2023 Earnings Release |
2022-07-27 17:28 | Q1 2023 Earnings Release |
2022-05-26 19:00 | FY 2022 Earnings Release |
2022-01-27 17:00 | Q3 2022 Earnings Release |
2021-10-28 17:15 | Interim 2022 Earnings Release |
2021-07-27 19:28 | Q1 2022 Earnings Release |
2021-05-19 17:30 | FY 2021 Earnings Release |
2021-01-27 17:46 | Q3 2021 Earnings Release |
2020-12-14 03:00 | Annual General Meeting |
2020-10-29 08:00 | Interim 2021 Earnings Call |
2020-10-28 17:15 | Interim 2021 Earnings Release |
2020-07-29 17:00 | Q1 2021 Earnings Release |
2020-05-20 08:00 | FY 2020 Earnings Call |
2020-05-19 17:30 | FY 2020 Earnings Release |
Past dividends on Taro Pharmaceutical Industries Ltd.
2018-12-09 | 12.81 USD |
Annual results
Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 670 697 -3.83% | 645 638 1.05% | 549 548 0.19% | 561 565 -0.66% | 573 577 -0.71% | 618 |
EBITDA Million USD | Released Forecast Spread | 311 375 -17.1% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 293 341 -14.18% | 247 259 -4.72% | 145 -331 143.82% | 125 81,8 52.76% | 17,7 13,8 28.75% | -1,24 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 357 365 -2.34% | 298 306 -2.54% | -391 -308 -26.91% | 77,9 94,9 -17.99% | 38,2 31,2 22.36% | 53,5 |
Net income Million USD | Released Forecast Spread | 282 275 2.64% | 244 249 -1.81% | -387 -322 -20.21% | 58,3 63,7 -8.52% | 25,4 27,0 -5.92% | 41,4 |
EPS USD | Released Forecast Spread | 7,23 7,98 -9.39% | 6,35 6,47 -1.85% | -10,1 -8,41 -20.33% | 1,55 1,70 -8.82% | 0,68 0,72 -5.56% | 1,10 |
Announcement Date | 22/05/19 | 19/05/20 | 19/05/21 | 27/05/22 | 24/05/23 | - |
Quarterly results
Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 148 147 0.69% | 147 137 7.2% | 132 153 -13.86% | 139 142 -2.28% | 143 147 -2.55% | 157 150 4.51% | 130 161 -18.96% | 139 163 -14.66% | 147 151 -2.72% | 159 149 6.62% | 161 | 155 | 156 |
EBIT Million USD | Released Forecast Spread | 38,1 40,7 -6.25% | 40,8 36,8 10.73% | 24,4 45,5 -46.32% | 37,0 39,6 -6.76% | 21,3 39,6 -46.26% | 14,0 37,9 -63.15% | -6,82 37,0 -118.44% | 1,28 36,7 -96.52% | 9,27 5,32 74.36% | -1,70 7,02 -124.21% | -1,10 | 1,03 | 0,91 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -37,8 45,2 -183.62% | -16,1 40,8 -139.36% | 29,4 49,3 -40.37% | 39,5 43,6 -9.49% | 25,0 42,1 -40.57% | 16,1 41,0 -60.87% | -4,91 40,5 -112.15% | 9,17 41,5 -77.91% | 17,9 10,9 63.93% | 5,44 15,3 -64.5% | 8,90 | 15,0 | 15,4 |
Net income Million USD | Released Forecast Spread | -29,8 35,2 -184.57% | -18,8 31,9 -158.9% | 23,3 38,5 -39.41% | 26,3 34,0 -22.71% | 27,4 32,8 -16.53% | 14,1 32,0 -56.01% | -2,81 31,6 -108.92% | 7,27 32,4 -77.57% | 6,91 8,52 -18.83% | 10,0 11,5 -12.7% | 6,68 | 11,3 | 11,6 |
EPS USD | Released Forecast Spread | -0,78 0,92 -184.78% | -0,50 0,84 -159.52% | 0,62 1,02 -39.22% | 0,70 0,91 -23.08% | 0,73 0,88 -17.05% | 0,37 0,85 -56.47% | -0,07 0,84 -108.33% | 0,19 0,87 -78.16% | 0,18 0,23 -21.74% | 0,27 0,31 -12.9% | 0,18 | 0,30 | 0,31 |
Announcement Date | 19/05/21 | 27/07/21 | 28/10/21 | 27/01/22 | 27/05/22 | 27/07/22 | 27/10/22 | 24/01/23 | 24/05/23 | 27/07/23 | - | - | - |
Past sector events for Taro Pharmaceutical Industries Ltd.
2024-05-03 07:07 | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
2024-05-03 06:00 | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-02 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-02 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
2024-05-02 16:01 | AMGEN INC.: Q1 2024 Earnings Release |
2024-05-02 13:43 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
2024-05-02 07:30 | ORGANON & CO.: Q1 2024 Earnings Release |
2024-05-02 07:00 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
2024-05-02 01:30 | NOVO NORDISK A/S: Q1 2024 Earnings Release |
2024-05-01 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TARO Stock
- Calendar Taro Pharmaceutical Industries Ltd.